StockData
Skye Bioscience, Inc. logo

Skye Bioscience, Inc. (SKYE) stock

SKYENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 3/30
$1.00−0.06 (-6.10%)

Close on Nov 17, 2026Market cap $35.42MP/E –Yield –

Skye Bioscience price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Skye Bioscience's price to book ratio was 17.7× on Jul 31, 2026, against 14.9× a year earlier. Over the last 4 years it ranged from 5.7× to 267.0×, with a median of 22.8×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jul 31, 202617.7×+12.1
2025Dec 31, 20255.7×−3.4
2024Dec 31, 20249.1×−149.3
2023Dec 29, 2023158.4×+109.0
2022Jul 29, 202249.4×+25.4
2021Dec 31, 202124.0×−19.2
2020Dec 31, 202043.2×–

More Skye Bioscience figures

See a number that looks wrong?